
NCPA Supports Medicare Medication Therapy Management Legislation
The bipartisan legislation would expand access to medication therapy management services for Medicare beneficiaries.
PRESS RELEASE
ALEXANDRIA, Va. (Mar. 18, 2015) —
“As medication experts, community pharmacists are critical to helping patients stick with and get the most out of their prescription drugs. Yet so much more can be done to improve medication adherence and achieve better health outcomes at lower overall costs.
“That is where medication therapy management, or MTM, services can play a vital role and it is why NCPA strongly supports this bipartisan legislation. S. 776 would expand MTM eligibility to Medicare beneficiaries with cardiovascular disease, chronic obstructive pulmonary disease, hyperlipidemia, or diabetes.
“Americans with chronic conditions earned a troubling C+ on the first
“We commend the leadership of Senators Pat Roberts (R-Kan.), Jeanne Shaheen (D-N.H.), Mark Kirk (R-Ill.) and Sherrod Brown (D-Ohio) on this legislation. We encourage their colleagues to cosponsor this legislation and ultimately enact it into law.”
###
The National Community Pharmacists Association (NCPA®) represents the interests of America's community pharmacists, including the owners of nearly 23,000 independent community pharmacies. Together they represent an $88.8 billion health care marketplace, dispense nearly 40% of all retail prescriptions, and employ more than 300,000 individuals, including over 62,000 pharmacists. To learn more, go to
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.













































































































































































































